| Ms Natasha Klimas, MD | |
|
6500 West Loop S Ste 200f, Bellaire, TX 77401-3535 | |
| (713) 500-8260 | |
| (713) 524-3432 |
| Full Name | Ms Natasha Klimas |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 6500 West Loop S Ste 200f, Bellaire, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215357355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | S0482 (Texas) | Primary |
| 207N00000X | Dermatology | S0482 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harris Health System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The University Of Texas Health Science Center At Houston | 8224936836 | 45 |
| Ut Physicians | 8426960360 | 1400 |
News Archive
UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.
Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning.
The ratio of practicing general surgeons to patients in the U.S. declined by 26% between 1981 and 2005, according to an analysis published Monday in the Archives of Surgery, Reuters reports.
Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.
BioMimetic Therapeutics, Inc. today announced it initiated enrollment in a pilot clinical trial to assess the safety and clinical utility of AugmentTM Rotator Cuff Graft for the repair of large rotator cuff tears. The randomized, controlled pilot trial is expected to include enrollment of up to 30 patients.
› Verified 2 days ago
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.
Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning.
The ratio of practicing general surgeons to patients in the U.S. declined by 26% between 1981 and 2005, according to an analysis published Monday in the Archives of Surgery, Reuters reports.
Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.
BioMimetic Therapeutics, Inc. today announced it initiated enrollment in a pilot clinical trial to assess the safety and clinical utility of AugmentTM Rotator Cuff Graft for the repair of large rotator cuff tears. The randomized, controlled pilot trial is expected to include enrollment of up to 30 patients.
› Verified 2 days ago
| Entity Name | The University Of Texas Health Science Center At Houston |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831142751 PECOS PAC ID: 8224936836 Enrollment ID: O20031220000059 |
News Archive
UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.
Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning.
The ratio of practicing general surgeons to patients in the U.S. declined by 26% between 1981 and 2005, according to an analysis published Monday in the Archives of Surgery, Reuters reports.
Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.
BioMimetic Therapeutics, Inc. today announced it initiated enrollment in a pilot clinical trial to assess the safety and clinical utility of AugmentTM Rotator Cuff Graft for the repair of large rotator cuff tears. The randomized, controlled pilot trial is expected to include enrollment of up to 30 patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Natasha Klimas, MD 6500 West Loop S Ste 200f, Bellaire, TX 77401-3535 Ph: (713) 500-8260 | Ms Natasha Klimas, MD 6500 West Loop S Ste 200f, Bellaire, TX 77401-3535 Ph: (713) 500-8260 |
News Archive
UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.
Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning.
The ratio of practicing general surgeons to patients in the U.S. declined by 26% between 1981 and 2005, according to an analysis published Monday in the Archives of Surgery, Reuters reports.
Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.
BioMimetic Therapeutics, Inc. today announced it initiated enrollment in a pilot clinical trial to assess the safety and clinical utility of AugmentTM Rotator Cuff Graft for the repair of large rotator cuff tears. The randomized, controlled pilot trial is expected to include enrollment of up to 30 patients.
› Verified 2 days ago
Dr. Peter Bryant-greenwood, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5909 West Loop S Ste 330, Bellaire, TX 77401 Phone: 833-749-8378 | |
Kevin Paul Rosenblatt, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4800 Fournace Pl Ste Be13, Bellaire, TX 77401 Phone: 713-542-8592 | |
Mitchell Charles Pilot, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5111 Linden St, Bellaire, TX 77401 Phone: 713-660-0860 |